Exhibit 107
Calculation of Filing Fee Tables
Form S-1
ArriVent BioPharma, Inc.
Table 1: Newly Registered Securities
| | | | | | | | | |
| | Security
Type | Security Class Title | Fee
Calculation
or Carry
Forward
Rule | Amount
Registered(1) | Proposed
Maximum
Offering
Price Per
Unit | Maximum
Aggregate
Offering
Price(2)(3) | Fee Rate | Amount of
Registration
Fee(4) |
| | | | | | | | | |
| Fees to Be Paid | Equity | Common Stock, par value $0.0001 per share | 457(a) | 9,583,332 | $19.00 | $182,083,308.00 | 0.00014760 | $26,875.50 |
| | | | | | |
| | Total Offering Amounts | | $182,083,308.00 | — | $26,875.50 |
| | | | | | |
| | Total Fees Previously Paid | | | | $14,760.00(5) |
| | | | | | |
| | Total Fee Offsets | | — | — | — |
| | | | | | |
| | Net Fee Due | | — | — | $12,115.50 |
| (1) | Includes 1,249,999 shares that the underwriters have the option to purchase. |
| (2) | Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(a) under the Securities Act of 1933, as amended, or the Securities Act. |
| (3) | Includes the aggregate offering price of 1,249,999 additional shares that the underwriters have the option to purchase. |
| (4) | Calculated pursuant to Rule 457(a) under the Securities Act. |
| (5) | The Registrant previously paid a registration fee of $14,760 in connection with the initial filing of this Registration Statement on Form S-1 on January 5, 2024. |
